Cargando…
135. Safety of Liver-Directed AAV2/8-Mediated Gene Transfer in a Large Animal Model of Lysosomal Storage Disease
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
The American Society of Gene & Cell Therapy. Published by Elsevier Inc.
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129429/ http://dx.doi.org/10.1016/S1525-0016(16)35939-1 |
| _version_ | 1783516784029073408 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7129429 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | The American Society of Gene & Cell Therapy. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71294292020-04-08 135. Safety of Liver-Directed AAV2/8-Mediated Gene Transfer in a Large Animal Model of Lysosomal Storage Disease Mol Ther Gene & Cell Therapy Genetic and Metabolic Disease: Metabolic and Lysosomal Storage Disorders The American Society of Gene & Cell Therapy. Published by Elsevier Inc. 2012-05 2016-12-14 /pmc/articles/PMC7129429/ http://dx.doi.org/10.1016/S1525-0016(16)35939-1 Text en Copyright © 2012 The American Society of Gene & Cell Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Gene & Cell Therapy Genetic and Metabolic Disease: Metabolic and Lysosomal Storage Disorders 135. Safety of Liver-Directed AAV2/8-Mediated Gene Transfer in a Large Animal Model of Lysosomal Storage Disease |
| title | 135. Safety of Liver-Directed AAV2/8-Mediated Gene Transfer in a Large Animal Model of Lysosomal Storage Disease |
| title_full | 135. Safety of Liver-Directed AAV2/8-Mediated Gene Transfer in a Large Animal Model of Lysosomal Storage Disease |
| title_fullStr | 135. Safety of Liver-Directed AAV2/8-Mediated Gene Transfer in a Large Animal Model of Lysosomal Storage Disease |
| title_full_unstemmed | 135. Safety of Liver-Directed AAV2/8-Mediated Gene Transfer in a Large Animal Model of Lysosomal Storage Disease |
| title_short | 135. Safety of Liver-Directed AAV2/8-Mediated Gene Transfer in a Large Animal Model of Lysosomal Storage Disease |
| title_sort | 135. safety of liver-directed aav2/8-mediated gene transfer in a large animal model of lysosomal storage disease |
| topic | Gene & Cell Therapy Genetic and Metabolic Disease: Metabolic and Lysosomal Storage Disorders |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129429/ http://dx.doi.org/10.1016/S1525-0016(16)35939-1 |